 Pavel Jedlicka
Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Ewing | 10 | 2023 | 65 | 3.430 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 6 | 2024 | 60 | 3.020 |
Why?
| | Oncogene Proteins, Fusion | 7 | 2024 | 179 | 2.050 |
Why?
| | Rhabdomyosarcoma | 3 | 2024 | 56 | 1.750 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 2 | 2024 | 19 | 1.660 |
Why?
| | MicroRNAs | 5 | 2017 | 600 | 1.240 |
Why?
| | Bone Neoplasms | 5 | 2017 | 191 | 1.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2024 | 1145 | 1.140 |
Why?
| | RNA-Binding Protein EWS | 5 | 2023 | 18 | 1.020 |
Why?
| | PAX3 Transcription Factor | 2 | 2024 | 12 | 0.950 |
Why?
| | Epigenesis, Genetic | 4 | 2024 | 518 | 0.930 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 5 | 2023 | 18 | 0.790 |
Why?
| | Cell Line, Tumor | 10 | 2024 | 2700 | 0.750 |
Why?
| | Chromatin | 1 | 2024 | 425 | 0.730 |
Why?
| | Forkhead Box Protein O1 | 1 | 2020 | 15 | 0.710 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 347 | 0.640 |
Why?
| | Epigenomics | 2 | 2017 | 98 | 0.640 |
Why?
| | Receptor, ErbB-4 | 1 | 2017 | 18 | 0.570 |
Why?
| | PTEN Phosphohydrolase | 1 | 2015 | 140 | 0.440 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2015 | 328 | 0.420 |
Why?
| | Somatomedins | 1 | 2011 | 28 | 0.380 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2010 | 51 | 0.340 |
Why?
| | Down-Regulation | 3 | 2017 | 594 | 0.330 |
Why?
| | Neoplasms | 2 | 2019 | 2086 | 0.300 |
Why?
| | Stem Cells | 1 | 2010 | 541 | 0.250 |
Why?
| | Heterografts | 2 | 2017 | 117 | 0.240 |
Why?
| | Paired Box Transcription Factors | 1 | 2024 | 37 | 0.240 |
Why?
| | Promoter Regions, Genetic | 2 | 2020 | 1131 | 0.230 |
Why?
| | Animals | 7 | 2024 | 31565 | 0.210 |
Why?
| | Homeodomain Proteins | 2 | 2023 | 465 | 0.190 |
Why?
| | Muscle Development | 1 | 2022 | 99 | 0.190 |
Why?
| | Base Sequence | 2 | 2017 | 2114 | 0.180 |
Why?
| | Humans | 13 | 2024 | 114045 | 0.180 |
Why?
| | Mice | 4 | 2024 | 14843 | 0.180 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2013 | 307 | 0.170 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 151 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2022 | 248 | 0.160 |
Why?
| | Signal Transduction | 1 | 2011 | 4501 | 0.150 |
Why?
| | Cell Proliferation | 2 | 2017 | 2173 | 0.150 |
Why?
| | Antagomirs | 1 | 2017 | 13 | 0.140 |
Why?
| | CD146 Antigen | 1 | 2017 | 35 | 0.140 |
Why?
| | 3' Untranslated Regions | 1 | 2017 | 129 | 0.130 |
Why?
| | Sequence Alignment | 1 | 2017 | 323 | 0.130 |
Why?
| | Mice, SCID | 1 | 2017 | 312 | 0.130 |
Why?
| | RNA Interference | 1 | 2017 | 431 | 0.120 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 552 | 0.120 |
Why?
| | Transcriptome | 1 | 2020 | 723 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 534 | 0.120 |
Why?
| | Neoplasm Metastasis | 1 | 2017 | 521 | 0.120 |
Why?
| | Transcription Factors | 1 | 2022 | 1526 | 0.110 |
Why?
| | Cell Movement | 1 | 2017 | 863 | 0.100 |
Why?
| | Clone Cells | 1 | 2013 | 247 | 0.100 |
Why?
| | Phenotype | 1 | 2020 | 2784 | 0.100 |
Why?
| | Mice, Nude | 1 | 2013 | 628 | 0.100 |
Why?
| | Child | 3 | 2023 | 18401 | 0.090 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2012 | 147 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1518 | 0.090 |
Why?
| | Gene Silencing | 1 | 2011 | 171 | 0.090 |
Why?
| | Up-Regulation | 1 | 2013 | 802 | 0.090 |
Why?
| | Soft Tissue Neoplasms | 1 | 2010 | 89 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 742 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 1875 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1311 | 0.060 |
Why?
| | Gene Expression | 1 | 2010 | 1417 | 0.060 |
Why?
| | Integrins | 1 | 2023 | 80 | 0.050 |
Why?
| | Myogenin | 1 | 2022 | 12 | 0.050 |
Why?
| | MyoD Protein | 1 | 2022 | 28 | 0.050 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 17 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 229 | 0.050 |
Why?
| | Adolescent | 1 | 2017 | 17800 | 0.040 |
Why?
| | Zebrafish | 1 | 2022 | 413 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2022 | 1696 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2322 | 0.030 |
Why?
| | Etoposide | 1 | 2012 | 149 | 0.020 |
Why?
| | Doxorubicin | 1 | 2012 | 286 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1014 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2012 | 636 | 0.020 |
Why?
|
|
Jedlicka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|